Skip to main content
. 2007 Aug;61(8):1256–1269. doi: 10.1111/j.1742-1241.2007.01458.x

Table 5.

Pain-free and headache relief with first dose, pain-free and headache relief with second dose as rescue medication, pain-free and headache relief with second dose to treat a recurrence/relapse (at 2 h postdose) and total pain-free rate with Indoprocaf-coated tablets and -effervescent tablets (intention-to-treat sample)*

First attack Second attack Total attacks



Indoprocaf tbs Indoprocaf effe Indoprocaf tbs Indoprocaf effe Indoprocaf tbs Indoprocaf effe
Pain-free (first dose) 16/72 (22) 29/71 (41) 23/70 (33) 25/63 (40) 39/142 (28) 54/134 (40)
Headache relief (first dose) 35/72 (49) 47/71 (66) 45/70 (64) 43/63 (68) 80/142 (56) 90/134 (67)
Pain-free (second doseas rescue medication) 11/27 (41) 10/19 (53) 6/16 (38) 6/9 (67) 17/43 (40) 16/28 (57)
Headache relief (second doseas rescue medication) 14/27 (52) 14/19 (74) 10/16 (63) 8/9 (89) 24/43 (56) 22/28 (79)
Pain-free (second doseto treat a recurrence/relapse) 4/8 (50) 9/18 (50) 8/9 (89) 6/10 (60) 12/17 (71) 15/28 (54)
Headache relief (second doseto treat a recurrence/relapse) 7/8 (88) 12/18 (67) 9/9 (100) 7/10 (70) 16/17 (94) 19/28 (68)
Total pain-free rate 52/72 (72) 60/71 (85) 52/70 (74) 53/63 (84) 104/142 (73) 113/134 (84)
*

Values are number of attacks complying with the parameter/total no. of attacks (percentage). Indoprocaf indicates indomethacin, prochlorperazine and caffeine; tbs indicates coated tablets; effe indicates effervescent tablets.

p < 0.05 vs. Indoprocaf tbs.

Total pain-free rate is the total percentage of attacks pain-free at 5 h without use of rescue medication and 2 h after the second dose of study drug as rescue medication.